The cohort study for live-style associated liver disease

The cohort study for live-style associated liver disease - The cohort study for live-style associated liver disease

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020303

Enrollment

Registered

2015-12-22

Start date

2015-03-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NAFLD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: We included the patients who underwent both elastography and bioelectrical impedance body composition evaluations.

Exclusion criteria

Exclusion criteria: We excluded the patients without NAFLD, the definition is described below. Exclusion criteria was set as no data of lever stiffness measurement, or no data of bio impedance analysis. After initial registration, the patients, with two or more elastography and bioelectrical impedance body composition evaluations, were extracted.

Design outcomes

Primary

Measure	Time frame
The change of the controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) determined by FibroScan (Echosens, Paris, France).	—

Countries

Japan

Contacts

Public ContactTakafumi Osaka

Kyoto Prefectural University of Medicine Graduate School of Medical Science Department of Endocrinology and Metabolism

tak-1314@koto.kpu-m.ac.jp+81-75-251-5505

Outcome results